Biogen Inc Stock Filter Stocks by Fundamentals
| BIIB Stock | USD 217.51 4.00 1.87% |
Biogen Inc fundamentals help investors to digest information that contributes to Biogen's financial success or failures. It also enables traders to predict the movement of Biogen Stock. The fundamental analysis module provides a way to measure Biogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biogen stock.
Biogen | Shares Owned by Institutions |
Biogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Biogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Biogen's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Biogen Institutional Holders
Institutional Holdings refers to the ownership stake in Biogen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biogen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biogen's value.| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.6 M | Legal & General Group Plc | 2023-12-31 | 1.6 M | T. Rowe Price Associates, Inc. | 2023-12-31 | 1.5 M | Northern Trust Corp | 2023-12-31 | 1.5 M | Norges Bank | 2023-12-31 | 1.5 M | Dimensional Fund Advisors, Inc. | 2023-12-31 | 1.4 M | Van Eck Associates Corporation | 2023-12-31 | 1.4 M | Bank Of New York Mellon Corp | 2023-12-31 | 1.4 M | Pictet Asset Manangement Sa | 2023-12-31 | 1.3 M | Primecap Management Company | 2023-12-31 | 16.3 M | Vanguard Group Inc | 2023-12-31 | 14.4 M |
Biogen Fundamentals
| Return On Equity | 0.0805 | ||||
| Return On Asset | 0.0486 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 37.54 B | ||||
| Shares Outstanding | 145.6 M | ||||
| Shares Owned By Insiders | 0.15 % | ||||
| Shares Owned By Institutions | 93.09 % | ||||
| Number Of Shares Shorted | 3.26 M | ||||
| Price To Earning | 14.83 X | ||||
| Price To Book | 1.95 X | ||||
| Price To Sales | 2.93 X | ||||
| Revenue | 9.84 B | ||||
| Gross Profit | 7.9 B | ||||
| EBITDA | 2.6 B | ||||
| Net Income | 1.16 B | ||||
| Cash And Equivalents | 4.91 B | ||||
| Cash Per Share | 34.10 X | ||||
| Total Debt | 7.34 B | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 2.49 X | ||||
| Book Value Per Share | 104.48 X | ||||
| Cash Flow From Operations | 1.55 B | ||||
| Short Ratio | 2.77 X | ||||
| Earnings Per Share | 8.00 X | ||||
| Price To Earnings To Growth | 6.24 X | ||||
| Target Price | 285.02 | ||||
| Number Of Employees | 7.57 K | ||||
| Beta | -0.009 | ||||
| Market Capitalization | 31.67 B | ||||
| Total Asset | 26.84 B | ||||
| Retained Earnings | 17.63 B | ||||
| Working Capital | 3.42 B | ||||
| Current Asset | 8.73 B | ||||
| Current Liabilities | 3.42 B | ||||
| Net Asset | 26.84 B |
About Biogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will appreciate offsetting losses from the drop in the long position's value.Moving together with Biogen Stock
| 0.62 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Moving against Biogen Stock
| 0.67 | QLI | Qilian International | PairCorr |
| 0.66 | SNDL | SNDL Inc Earnings Call This Week | PairCorr |
| 0.63 | IMCC | Im Cannabis Corp Earnings Call This Week | PairCorr |
| 0.56 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.45 | PAHC | Phibro Animal Health Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Biogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biogen Inc to buy it.
The correlation of Biogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biogen Piotroski F Score and Biogen Altman Z Score analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 8 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.